Positron Corporation (POSC)

[crammerfool]

CANCER VIDEO: Cost of Imaging Increasing For Cancer Patients, Obese Children Metabolize Medication Differently, High Dose B Vitamin Linked With Kidney Function Decline

http://www.insidermedicine.ca/archives/CANCER_VIDEO_Cost_of_Imaging_Increasing_For_Cancer_Patients_Difference_in_How_Obese_Children_Metabolize_Medication_High_Dose_B_Vitamin_Therapy_Linked_With_Kidney_Function_Decline_4277.aspx

(April 27, 2010 - Insidermedicine)

From North Carolina – According to a report published in the Journal of the American Medical Association, the cost of imaging patients with cancer has increased in the last seven years. From 1999 to 2006, researchers found that use of imaging tests such as echocardiogram, MRI, ultrasound and CT scans all increased, with positron emission tomography (PET) increasing the most. As a result, the average 2 year imaging cost per beneficiary doubled.


From California – Children who are obese metabolize medications differently than those of healthy weight, according to a report presented at the annual meeting for the American Society for Pharmacology and Experimental Therapeutics. Researchers examined both obese and healthy weight children, finding a noticeable difference in how the two groups metabolized the drug dextromethorphan.


And finally, from London – According to another report published in the Journal of the American Medical Association, diabetic nephropathy patients who undergo B vitamin therapy may be at increased risk of kidney function decline. Researchers randomized over 200 diabetic patients to either high dose B vitamin therapy or placebo. Results showed that the B vitamin group had poorer kidney function and a greater amount of cardiovascular outcomes, including heart attack and stroke.